Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kylonova (xiamen) Biopharma Co., Ltd.

Clinical trials sponsored by Kylonova (xiamen) Biopharma Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug Kylo-11 aims to tackle stubborn heart disease risk factor Results expected Feb 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug Kylo-11 aims to tackle stubborn heart disease risk factor

Disease control Recruiting now

This phase 2 trial tests Kylo-11, an experimental drug, in 204 adults with heart disease and high levels of lipoprotein(a) – a genetic risk factor for heart attacks and strokes. Participants receive either Kylo-11 or a placebo injection for about a year. The main goal is to see i…

Phase 2 • Sponsor: Kylonova (Xiamen) Biopharma co., LTD. • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC